These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17685890)

  • 1. Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer.
    Papadavid E; Stratigos AJ; Falagas ME
    Expert Opin Pharmacother; 2007 Aug; 8(11):1743-55. PubMed ID: 17685890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases.
    Ulrich C; Busch JO; Meyer T; Nindl I; Schmook T; Sterry W; Stockfleth E
    Br J Dermatol; 2006 Aug; 155(2):451-4. PubMed ID: 16882188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imiquimod in dermatology: an overview.
    Hanna E; Abadi R; Abbas O
    Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
    Stockfleth E; Meyer T; Benninghoff B; Christophers E
    Br J Dermatol; 2001 May; 144(5):1050-3. PubMed ID: 11359396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.
    Wagstaff AJ; Perry CM
    Drugs; 2007; 67(15):2187-210. PubMed ID: 17927284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod in basal cell carcinoma: how does it work?
    Dummer R; Urosevic M; Kempf W; Hoek K; Hafner J; Burg G
    Br J Dermatol; 2003 Nov; 149 Suppl 66():57-8. PubMed ID: 14616353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
    Gupta AK; Davey V; Mcphail H
    J Cutan Med Surg; 2005 Oct; 9(5):209-14. PubMed ID: 16502198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod (Aldara) for actinic keratoses.
    Med Lett Drugs Ther; 2004 May; 46(1183):42-4. PubMed ID: 15159659
    [No Abstract]   [Full Text] [Related]  

  • 9. Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod.
    Torres A; Storey L; Anders M; Miller RL; Bulbulian BJ; Jin J; Raghavan S; Lee J; Slade HB; Birmachu W
    Br J Dermatol; 2007 Dec; 157(6):1132-47. PubMed ID: 17944981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].
    Oster-Schmidt C; Altmeyer P; Markus S
    J Dtsch Dermatol Ges; 2003 Oct; 1(10):790-6. PubMed ID: 16281815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod 5% cream for actinic keratosis.
    Perras C
    Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New perspective in immunotherapy: local imiquimod treatment].
    Kemény L; Nagy N
    Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive imaging, treatment, and microscopic confirmation of clearance of basal cell carcinoma.
    Goldgeier M; Fox CA; Zavislan JM; Harris D; Gonzalez S
    Dermatol Surg; 2003 Mar; 29(3):205-10. PubMed ID: 12614409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating actinic keratoses with imiquimod.
    Dixon A
    Aust Fam Physician; 2007 May; 36(5):341-2. PubMed ID: 17492069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle.
    Berman B; Sullivan T; De Araujo T; Nadji M
    Br J Dermatol; 2003 Nov; 149 Suppl 66():59-61. PubMed ID: 14616354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial.
    Peris K; Campione E; Micantonio T; Marulli GC; Fargnoli MC; Chimenti S
    Dermatol Surg; 2005 Mar; 31(3):318-23. PubMed ID: 15841634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is imiquimod effective and safe for actinic keratosis?
    Walker JK; Koenig C
    J Fam Pract; 2003 Mar; 52(3):184-5. PubMed ID: 12620165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
    Urosevic M; Dummer R; Conrad C; Beyeler M; Laine E; Burg G; Gilliet M
    J Natl Cancer Inst; 2005 Aug; 97(15):1143-53. PubMed ID: 16077073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer.
    Garcia-Mouronte E; Berna-Rico E; de Nicolas-Ruanes B; Azcarraga-Llobet C; Alonso-Martinez de Salinas L; Bea-Ardebol S
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis.
    Persaud AN; Shamuelova E; Sherer D; Lou W; Singer G; Cervera C; Lamba S; Lebwohl MG
    J Am Acad Dermatol; 2002 Oct; 47(4):553-6. PubMed ID: 12271300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.